{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:00Z","timestamp":1787013900113,"version":"build-2736575974"},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To investigate the\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      interval after high dose droperidol using continuous 12\u2010lead Holter recordings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a prospective study of patients given droperidol with a continuous Holter recording. Patients were recruited from the\n                      <jats:styled-content style=\"fixed-case\">DORM II<\/jats:styled-content>\n                      study which included patients with aggression presenting to the emergency department. Patients initially received 10\u2009mg droperidol as part of a standardized sedation protocol. An additional 10\u2009mg dose was given after 15\u2009min if required and further doses at the clinical toxicologist's discretion. Continuous 12\u2010lead Holter recordings were obtained for 2\u201324\u2009h utilizing high resolution digital recordings with automated\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      interval measurement. Electrocardiograms were extracted hourly from Holter recordings. The\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      interval was plotted against heart rate (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      ) on the\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      nomogram to determine if it was abnormal.\n                      <jats:styled-content style=\"fixed-case\">\n                        QT\n                        <jats:sub>c<\/jats:sub>\n                        F\n                      <\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>\n                      ridericia's\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      correction) was calculated and &gt;500\u2009ms was defined as abnormal.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty\u2010six patients had Holter recordings after 10\u201340\u2009mg droperidol and 316\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      \u2013\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      pairs were included. There were 32 abnormal\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      measurements in four patients, three given 10\u2009mg and one 20\u2009mg. In three of the four patients\n                      <jats:styled-content style=\"fixed-case\">\n                        QT\n                        <jats:sub>c<\/jats:sub>\n                        F\n                      <\/jats:styled-content>\n                      &gt;500\u2009ms but only in one taking methadone was the timing of\n                      <jats:styled-content style=\"fixed-case\">\n                        QT\n                        <jats:sub>c<\/jats:sub>\n                        F\n                      <\/jats:styled-content>\n                      &gt;500\u2009ms consistent with droperidol dosing. Of the three other patients, one took amphetamines, one still had\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      prolongation 24\u2009h after droperidol and one took a lamotrigine overdose. No patient given &gt;30\u2009mg had a prolonged\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      . There were no arrhythmias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      prolongation was observed with high dose droperidol. However, there was little evidence supporting droperidol being the cause and\n                      <jats:styled-content style=\"fixed-case\">QT<\/jats:styled-content>\n                      prolongation was more likely due to pre\u2010existing conditions or other drugs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bcp.12272","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T03:20:50Z","timestamp":1383103250000},"page":"880-886","source":"Crossref","is-referenced-by-count":32,"title":["High dose droperidol and\n                    <scp>QT<\/scp>\n                    prolongation: analysis of continuous 12\u2010lead recordings"],"prefix":"10.1111","volume":"77","author":[{"given":"Leonie","family":"Calver","sequence":"first","affiliation":[{"name":"School of Medicine and Public Health University of Newcastle  Newcastle New South Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey K.","family":"Isbister","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health University of Newcastle  Newcastle New South Wales"},{"name":"Department of Clinical Toxicology and Pharmacology Calvary Mater Newcastle  Newcastle New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(03)00044-1"},{"key":"e_1_2_9_3_1","first-page":"932","article-title":"Droperidol: cardiovascular toxicity and deaths","volume":"166","author":"Wooltorton E","year":"2002","journal-title":"CMAJ"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2003.110"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1197\/aemj.9.6.615"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000281893.39781.64"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2009.01182.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-227X-10-14"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.05.037"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2005.07.003"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(98)00045-6"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1197\/j.aem.2005.07.017"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1197\/aemj.9.12.1402"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199411000-00028"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2004.08.005"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.07.118"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12040"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2011.01484.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm072"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2004.10.002"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.597035"},{"key":"e_1_2_9_22_1","first-page":"541","article-title":"[Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol]","volume":"40","author":"Guy JM","year":"1991","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200506000-00007"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124050-00001"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(03)00008-X"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009933509868"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/22.1.67"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31817fd8c8"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650903333820"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90036-C"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200506000-00006"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.12272","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T10:44:43Z","timestamp":1696329883000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1111\/bcp.12272"],"URL":"https:\/\/doi.org\/10.1111\/bcp.12272","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]}}}